- Home
- PCRX vs EU Comparison
PCRX vs EU Comparison
Compare PCRX & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- EU
- Stock Information
- Founded
- PCRX 2006
- EU 2009
- Country
- PCRX United States
- EU United States
- Employees
- PCRX N/A
- EU N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- EU Other Metals and Minerals
- Sector
- PCRX Health Care
- EU Basic Materials
- Exchange
- PCRX Nasdaq
- EU Nasdaq
- Market Cap
- PCRX 604.7M
- EU 652.4M
- IPO Year
- PCRX 2011
- EU N/A
- Fundamental
- Price
- PCRX $22.81
- EU $3.56
- Analyst Decision
- PCRX Buy
- EU Strong Buy
- Analyst Count
- PCRX 10
- EU 2
- Target Price
- PCRX $27.60
- EU $6.50
- AVG Volume (30 Days)
- PCRX 787.3K
- EU 1.4M
- Earning Date
- PCRX 02-27-2025
- EU 11-14-2024
- Dividend Yield
- PCRX N/A
- EU N/A
- EPS Growth
- PCRX N/A
- EU N/A
- EPS
- PCRX N/A
- EU N/A
- Revenue
- PCRX $694,957,000.00
- EU $44,972,063.00
- Revenue This Year
- PCRX $4.83
- EU N/A
- Revenue Next Year
- PCRX $2.16
- EU $55.73
- P/E Ratio
- PCRX N/A
- EU N/A
- Revenue Growth
- PCRX 4.40
- EU N/A
- 52 Week Low
- PCRX $11.16
- EU $3.02
- 52 Week High
- PCRX $34.01
- EU $5.05
- Technical
- Relative Strength Index (RSI)
- PCRX 71.48
- EU 54.33
- Support Level
- PCRX $18.18
- EU $3.26
- Resistance Level
- PCRX $22.88
- EU $3.60
- Average True Range (ATR)
- PCRX 1.14
- EU 0.18
- MACD
- PCRX 0.32
- EU 0.01
- Stochastic Oscillator
- PCRX 96.36
- EU 52.54
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's material properties and projects are the Rosita Project located in Texas, the Alta Mesa Uranium project in Texas, the Crownpoint and Hosta Butte Uranium Project located in New Mexico, the Dewey Burdock Project located in South Dakota, and the Gas Hills Project located in Wyoming.